New YorkRequires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic
What it does
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- May 4PRINT NUMBER 9010BLatest
- May 4AMEND AND RECOMMIT TO HEALTHMajor
- Jan 22PRINT NUMBER 9010AMajor
- Jan 22AMEND AND RECOMMIT TO HEALTHMajor
- Jan 7REFERRED TO HEALTHMinor
- 2025
- Aug 13REFERRED TO HEALTHIntroduced